Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype

Tissue Antigens

Volumn 79, Issue 2, 2012, Pages 90-96

  Tajik, N ^a   Shah hosseini, A ^a   Mohammadi, A ^a   Jafari, M ^a   Nasiri, M ^a   Radjabzadeh, M F ^a   Farnia, P ^b   Jalali, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genotyping; HLA genes; KIR genes; NK cells; Tuberculosis

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENOTYPE; HUMAN; IRAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADAPTIVE IMMUNITY; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; IRAN; KILLER CELLS, NATURAL; MALE; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; POLYMERASE CHAIN REACTION; RECEPTORS, KIR; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84855475731     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01812.x     Document Type: Article

References (47)

1. WHO. Global Tuberculosis Control: Epidemiology, Strategy, Financing: WHO Report 2009, Geneva, Switzerland: WHO Press, World Health Organisation, 2009; ISBN 978 92 4 156380 2.
2. Eley BS, Beatty DW. The basic immunology of tuberculosis. In: Schaaf S, Zumla A, eds. Tuberculosis: A Comprehensive Clinical Reference, Philadelphia, PA: Saunders, 2009, 75-86.
3. Lawn SD, Butera ST, Shinnick TM. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microbes Infect 2002: 4: 635-46.
4. Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008: 122: 1043-51. (quiz 52-3).
5. French AR, Yokoyama WM. Natural killer cells and viral infections. Curr Opin Immunol 2003: 15: 45-51.
6. Vankayalapati R, Garg A, Porgador A et al. Role of natural killer cell activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2005: 175: 4611-7.
7. Vankayalapati R, Klucar P, Wizel B et al. NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J Immunol 2004: 172: 130-7.
8. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse T regulatory cells in human infection with an intracellular pathogen. J Immunol 2008: 180: 1729-36.
9. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008: 9: 495-502.
10. Steffens U, Vyas Y, Dupont B, Selvakumar A. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR). Tissue Antigens 1998: 51: 398-413.
11. Wilson MJ, Torkar M, Haude A et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci U S A 2000: 97: 4778-83.
12. Trowsdale J. Genetic and functional relationships between MHC and NK receptor genes. Immunity 2001: 15: 363-74.
13. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 2001: 52: 195-205.
14. Witt CS, Dewing C, Sayer DC, Uhrberg M, Parham P, Christiansen FT. Population frequencies and putative haplotypes of the killer cell immunoglobulin-like receptor sequences and evidence for recombination. Transplantation 1999: 68: 1784-9.
15. Crum KA, Logue SE, Curran MD, Middleton D. Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires. Tissue Antigens 2000: 56: 313-26.
16. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997: 7: 753-63.
17. Williams F, Maxwell LD, Halfpenny IA et al. Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals. Hum Immunol 2003: 64: 729-32.
18. Gomez-Lozano N, Gardiner CM, Parham P, Vilches C. Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 2002: 54: 314-9.
19. Martin MP, Bashirova A, Traherne J, Trowsdale J, Carrington M. Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 2003: 171: 2192-5.
20. Hsu KC, Chida S, Geraghty DE, Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 2002: 190: 40-52.
21. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002: 54: 221-9.
22. Rajalingam R. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses. Iran J Immunol 2007: 4: 61-78.
23. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nature Immunol 2008: 9: 503-10.
24. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005: 5: 201-14.
25. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A 1993: 90: 12000-4.
26. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor re-veal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995: 2: 439-49.
27. Winter CC, Long EO. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 1997: 158: 4026-8.
28. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998: 161: 571-7.
29. Gumperz JE, Litwin V, Phillips JH, Lanier LL, Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995: 181: 1133-44.
30. Thananchai H, Gillespie G, Martin MP et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 2007: 178: 33-7.
31. Pende D, Biassoni R, Cantoni C et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 1996: 184: 505-18.
32. Dohring C, Scheidegger D, Samaridis J, Cella M, Colonna M. A human killer inhibitory receptor specific for HLA-A1, 2. J Immunol 1996: 156: 3098-101.
33. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 1994: 180: 1235-42.
34. Sivori S, Carlomagno S, Falco M, Romeo E, Moretta L, Moretta A. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood 2011: 117: 4284-92.
35. Alter G, Martin MP, Teigen N et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007: 204: 3027-36.
36. Du Z, Gjertson DW, Reed EF, Rajalingam R. Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 2007: 59: 1-15.
37. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
38. Tajik N, Shahsavar F, Mousavi T, Radjabzadeh MF. Distribution of KIR genes in the Iranian population. Tissue Antigens 2009: 74: 22-31.
39. Tajik N, Shahsavar F, Nasiri MR, Radjabzadeh MF. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. Int J Immnogenetics 2010: 37: 159-168.
40. McQueen KL, Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum Immunol 2007: 68: 309-23.
41. Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acid Research 2011: 39: D913-D919.
42. Vankayalapati R, Barnes PF. Innate and adaptive immune responses to human Mycobacterium tuberculosis infection. Tuberculosis 2009: 89: S77-S80.
43. Garg A, Barnes PF, Quiroga MF et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol 2008: 38: 459-69.
44. Mendez A, Granda H, Meenagh A et al. Study of KIR genes in tuberculosis patients. Tissue Antigens 2006: 68: 386-9.
45. Dye C, Williams BG. The population dynamics and control of tuberculosis. Science 2010: 328: 856-61.
46. Ma J, Guo X, Wu X et al. Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population. J Med Virol 2010: 82: 1501-7.
47. Choy MK, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med 2010: 16: 97-106.